Safety Assessment of the Modified Lactoperoxidase System-In Vitro Studies on Human Gingival Fibroblasts.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
30 Jan 2023
Historique:
received: 15 12 2022
revised: 19 01 2023
accepted: 27 01 2023
entrez: 11 2 2023
pubmed: 12 2 2023
medline: 15 2 2023
Statut: epublish

Résumé

One strategy in caries prevention is to inhibit the formation of cariogenic biofilms. Attempts are being made to develop oral hygiene products enriched with various antimicrobial agents. One of them is lactoperoxidase-an enzyme that can oxidise (pseudo)halide ions to reactive products with antimicrobial activity. Currently, commercially available products utilise thiocyanate as a substrate; however, several alternatives that are oxidised to products with greater antimicrobial potential have been found. In this study, toxicity against human gingival fibroblasts of the lactoperoxidase system was evaluated using four different (pseudo)halide substrate systems-thiocyanate, iodide, selenocyanate, and a mixture of thiocyanate and iodide. For this purpose, cells were treated with the systems and then apoptosis, cell cycle, intracellular glutathione concentration, and mitochondrial superoxide production were assessed. The results showed that each system, after generating 250 µM of the product, inhibited cell divisions, increased apoptosis, and increased the percentage of dead cells. It was concluded that the mechanism of the observed phenomena was not related to increased superoxide production or the depletion of glutathione concentration. These findings emphasised the need for the further in vitro and in vivo toxicity investigation of the modified lactoperoxidase system to assess its safety and the possibility of use in oral hygiene products.

Identifiants

pubmed: 36768964
pii: ijms24032640
doi: 10.3390/ijms24032640
pmc: PMC9916481
pii:
doi:

Substances chimiques

Hydrogen Peroxide BBX060AN9V
Iodides 0
Lactoperoxidase EC 1.11.1.-
Superoxides 11062-77-4
thiocyanate O748SU14OM
Thiocyanates 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Jagiellonian University
ID : N42/DBS/000199
Organisme : AGH University of Science and Technology
ID : 16.16.160.557
Organisme : Jagiellonian University
ID : N41/DBS/000162
Organisme : Jagiellonian University
ID : K/ZDS/005485
Organisme : National Science Center
ID : 2021/41/N/NZ7/03315

Références

J Inorg Biochem. 2016 Jan;154:35-41
pubmed: 26580225
Eur J Clin Nutr. 2022 Apr;76(4):629-630
pubmed: 34471253
Free Radic Biol Med. 2004 Sep 15;37(6):839-49
pubmed: 15384204
React Oxyg Species (Apex). 2016;2(5):361-370
pubmed: 29721549
Nutrients. 2017 Nov 14;9(11):
pubmed: 29135948
Folia Med Cracov. 2015;55(1):43-51
pubmed: 26774631
Free Radic Res. 2016 Dec;50(12):1287-1295
pubmed: 27629563
Chem Res Toxicol. 2009 Nov;22(11):1833-40
pubmed: 19821602
BMC Microbiol. 2014 Aug 05;14:194
pubmed: 25096795
Int J Mol Sci. 2019 Apr 16;20(8):
pubmed: 30995738
Am J Public Health. 1981 Dec;71(12):1320-4
pubmed: 7315995
Molecules. 2018 Oct 08;23(10):
pubmed: 30297621
Folia Med Cracov. 2020;60(4):5-17
pubmed: 33821847
Braz J Med Biol Res. 2021 Jan 08;54(2):e10197
pubmed: 33439932
Free Radic Biol Med. 2002 Oct 15;33(8):1061-72
pubmed: 12374617
Cell Biol Toxicol. 2003 Nov;19(6):339-53
pubmed: 15015759
FASEB J. 2003 Aug;17(11):1502-4
pubmed: 12824283
Med Biol. 1983;61(5):268-74
pubmed: 6686988
Anticancer Res. 2022 Jun;42(6):2819-2825
pubmed: 35641293
J Dent Hyg. 2009 Summer;83(3):111-6
pubmed: 19723429
J Adv Res. 2017 Jul;8(4):387-392
pubmed: 28560054
Pharmaceutics. 2019 Jul 10;11(7):
pubmed: 31295834
Int J Mol Sci. 2019 Mar 21;20(6):
pubmed: 30901933
Antioxidants (Basel). 2021 Apr 26;10(5):
pubmed: 33926051
J Dent Res. 2008 Oct;87(10):900-14
pubmed: 18809743
Antioxidants (Basel). 2021 Oct 20;10(11):
pubmed: 34829517
Arch Oral Biol. 1984;29(6):445-51
pubmed: 6589987
Infect Immun. 1983 Apr;40(1):70-80
pubmed: 6832837
Enzyme Res. 2014;2014:517164
pubmed: 25309750
Arch Biochem Biophys. 2000 Aug 1;380(1):181-91
pubmed: 10900148
J Clin Med. 2018 Oct 15;7(10):
pubmed: 30326618
J Clin Periodontol. 2002 Mar;29(3):189-94
pubmed: 11940135
J Hosp Infect. 1999 Nov;43(3):219-29
pubmed: 10582189
Free Radic Biol Med. 2020 Jan;146:324-332
pubmed: 31740228
J Clin Diagn Res. 2014 Apr;8(4):ZC18-20
pubmed: 24959510
J Biol Chem. 2013 Jun 21;288(25):18421-8
pubmed: 23629660
Cell Death Differ. 2002 Sep;9(9):1007-16
pubmed: 12181751
J Biol Chem. 1991 Mar 15;266(8):4903-10
pubmed: 2002037
Support Care Cancer. 2007 Dec;15(12):1429-36
pubmed: 17235501
Free Radic Biol Med. 2012 Apr 15;52(8):1343-52
pubmed: 22330063
Drug Des Devel Ther. 2016 Feb 04;10:557-70
pubmed: 26893544

Auteurs

Marcin Magacz (M)

Department of Medical Diagnostics, Faculty of Pharmacy, Jagiellonian University Medical College, Medyczna 9, 30-688 Kraków, Poland.
Doctoral School of Health and Medical Sciences, Jagiellonian University Medical College, Św. Łazarza 16, 31-008 Kraków, Poland.

Monika Papież (M)

Department of Cytobiology, Faculty of Pharmacy, Jagiellonian University Medical College, Medyczna 9, 30-688 Kraków, Poland.

Dorota Kościelniak (D)

Department of Pediatric Dentistry, Institute of Dentistry, Jagiellonian University Medical College, Montelupich 4, 31-155 Kraków, Poland.

Anna Jurczak (A)

Department of Pediatric Dentistry, Institute of Dentistry, Jagiellonian University Medical College, Montelupich 4, 31-155 Kraków, Poland.

Karolina Kędziora (K)

Department of Medical Diagnostics, Faculty of Pharmacy, Jagiellonian University Medical College, Medyczna 9, 30-688 Kraków, Poland.

Elżbieta Pamuła (E)

Department of Biomaterials and Composites, Faculty of Materials Science and Ceramics, AGH University of Science and Technology, Al. Mickiewicza 30, 30-059 Kraków, Poland.

Wirginia Krzyściak (W)

Department of Medical Diagnostics, Faculty of Pharmacy, Jagiellonian University Medical College, Medyczna 9, 30-688 Kraków, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH